Singaporean Biotech Startup Hummingbird Closes US$25M Extended Series B

Hummingbird

With the latest investment, Hummingbird’s total funding till date crosses US$65 million

Singapore-based biotherapeutics startup Hummingbird Bioscience announced on Monday the close of an extended Series B funding round of US$25 million, led by new investor SK Holdings, who invested close to $6.5 million.

Due to significant over-subscription, Hummingbird’s Series B round was extended to add close to $7 million to the previously-raised $19 million from December 2019, bringing the total funding from Series B to $25 million. The earlier part of the round was co-led by Mirae Asset Venture Investment and GNTech Venture Capital. The latest investment brings the total capital raised by Hummingbird to more than $65 million.

Existing investors who also participated in the round include Heritas Capital Management and SEEDS Capital, the investment arm of Enterprise Singapore, a government agency that supports small-and-medium-sized enterprises.

Some of Hummingbird’s other investors include Delian Capital, Decheng Capital, Mirae Asset Capital, DAValue-GiltEdge, HB Investment, Wooshin Venture Investment, and Kiwoom Investment-Shinhan Capital.

Hummingbird will use the latest funds to accelerate development of new candidates into clinical trials and strengthen its scientific and research and development capabilities, the company said.

Founded in 2015, the biotech company researches novel antibody-based therapeutics called immunoproteins that selectively target and destroy malignant proteins that act as starting points for diseases and tumors.

Hummingbird uses systems biology to develop insights into disease biology, and applies computationally guided platforms to discover and engineer breakthrough antibody therapeutics for difficult-to-treat conditions, mostly cancer.

The company published data earlier this year on two antibodies, both oncology treatments, and expects to make regulatory submissions to initiate Phase 1 studies in the second half of this year.

“Hummingbird is building a strong portfolio of promising new therapies that we believe can deliver very meaningful benefit for patients across a broad spectrum of disease. These new funds give us further resources to develop our early stage pipeline, and support the clinical development of our lead programs,” said Dr Piers Ingram, Co-founder and CEO, Hummingbird Bioscience.

According to their website, Hummingbird now has more than 30 senior scientists and research associates in Singapore, with expertise in Antibody Discovery & Engineering, Pharmacology & Production, and Clinical Development. The startup also has Business Development centers in Houston, Texas and South San Francisco, California.

Hummingbird Bioscience has established strategic collaborations with Cancer Research UK and Amgen, and has been awarded a product development grant from the Cancer Prevention and Research Institute of Texas.

CEO and Executive Director, Heritas Capital Management, Chik Wai Chiew said, “Even as the COVID-19 pandemic has resulted in a slow-down in investing, we are mindful that backing leading innovative biotech companies, especially players such as Hummingbird, to develop cures for addressing patients’ needs remains our priority.”

Hummingbird’s funding round is the latest in a line of healthtech fundraises and acquisitions from Q1 of 2020.

Header Image Courtesy of Hummingbird Bioscience

SHARE THIS STORY

Share on facebook
Share on twitter
Share on linkedin
Share on email

RELATED POSTS

Cultos Global Lands Major Investment to Advance Web3 Brand Engagement Solutions

Cultos Global Lands Major Investment to Advance Web3 Brand Engagement Solutions

Dubai-based Web3 company, Cultos Global, has recently acquired substantial investment in its latest funding round. The specific amount remains undisclosed. This venture specializes in altering the dynamics of brand-customer relationships by launching a sophisticated, integrated platform that intertwines digital marketing and customer rewards, converting conventional consumers into active nano-influencers.

Navigating the Growing Crisis of Space Debris

Orbital Fallout: Navigating the Growing Crisis of Space Debris

Ever since we stepped into the space age back in the 1950s, we’ve been busily sending rockets and satellites up, up and away, painting our mark way beyond our planetary borders. But here’s the thing—our ventures have left the cosmos littered with about 2,000 operational satellites and another 3,000 that are just space junk now.

Pryon Secures US$100 Million in Series B to Advance AI in Knowledge Management

Pryon Secures US$100 Million in Series B to Advance AI in Knowledge Management

Pryon Inc., a North Carolina-based company specializing in integrating artificial intelligence (AI) with knowledge management, has completed a Series B investment round, raising US$100 million. The funding was led by Thomas Tull’s US Innovative Technology Fund (USIT), with contributions from both new and existing investors, including Aperture Venture Capital,

Amazon Launches Upgraded AI Enhanced Fire TV Sticks

Amazon Launches Upgraded AI Enhanced Fire TV Sticks

Amazon has rolled out a series of updates to its Fire TV offerings. The new features include an improved conversational voice search powered by generative AI and Fire TV Ambient Experience advancements. Among the latest hardware releases are the Fire TV Stick 4K Max and the Fire TV Stick 4K, incorporating the enhanced Fire TV Ambient Experience.

Interactive Learning with Augmented Reality

Interactive Learning with Augmented Reality: Applications, Benefits and Challenges

Ever wondered what it would be like if your textbooks could talk, if the illustrations in your lessons could come to life, or if you could step into history rather than just read about it? Welcome to the world of augmented reality (AR) in education! Like a magic wand, AR can turn the abstract into tangible and the mundane into extraordinary, unfolding boundless educational possibilities.